• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

间充质干细胞衍生的外泌体 mir-21-5p 抑制 Yap1 表达并改善心肌梗死的预后。

Mesenchymal stem cell-derived exosomal mir-21-5p inhibits YAP1 expression and improves outcomes in myocardial infarction.

机构信息

Department of Cardiovascular Medicine, The Third Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning, China.

Jinzhou Hospital of Traditional Chinese Medicine, No. 91, Shifu Road, Taihe District, Jinzhou, Liaoning, 121000, China.

出版信息

BMC Cardiovasc Disord. 2024 Oct 10;24(1):547. doi: 10.1186/s12872-024-04197-z.

DOI:10.1186/s12872-024-04197-z
PMID:39385107
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11465913/
Abstract

BACKGROUND

Myocardial infarction (MI) remains a significant global health concern, characterized by cardiomyocyte apoptosis and adverse ventricular remodeling. Nevertheless, the interplay between exosomal miR-21-5p and Yes-associated protein 1 (YAP1) in the context of MI remains unexplored.

METHODS

Rat mesenchymal stem cells (MSCs) and H9c2 cardiomyocytes were cultured, characterized, and instrumental in our experiments. Exosomes were meticulously isolated, and their identity confirmed. The internalization of these exosomes by H9c2 cells was assessed, while RNA and protein expression were quantified using Quantitative Real-Time PCR and Western blot, respectively. MTT assay was implemented for cell viability, and apoptosis was evaluated via flow cytometric analysis. To elucidate gene interactions, we conducted microarray profiling of miRNA expression, dual luciferase reporter assays, and RNA Immunoprecipitation.

RESULTS

MSC-derived exosomes exhibited a remarkable capacity to attenuate hypoxia-induced inflammation and apoptosis in H9c2 cells. Notably, these exosomes significantly upregulated miR-21-5p levels within H9c2 cells, and the abrogation of miR-21-5p function abated their protective effects. Through computational analysis, we unveiled a miR-21-5p binding site in the 3'UTR of YAP1, which directly inhibited YAP1 expression. Importantly, the inhibition of YAP1 effectively reinstated the protective effects of exosomes in cells with impaired exosomal miR-21-5p.

CONCLUSION

This study underscores the pivotal role played by MSC-derived exosomes in safeguarding against MI, primarily by mediating the transfer of miR-21-5p, which targets YAP1 signaling pathways.

CLINICAL TRIAL NUMBER

N/A.

摘要

背景

心肌梗死(MI)仍然是一个重大的全球健康问题,其特征是心肌细胞凋亡和心室重构不良。然而,miR-21-5p 外泌体与 Yes 相关蛋白 1(YAP1)在 MI 背景下的相互作用仍未被探索。

方法

培养大鼠间充质干细胞(MSCs)和 H9c2 心肌细胞,并对其进行特征鉴定,这些细胞在我们的实验中发挥了重要作用。精心分离外泌体,并确认其身份。评估这些外泌体被 H9c2 细胞内化的情况,同时使用定量实时 PCR 和 Western blot 分别定量 RNA 和蛋白质表达。通过 MTT 测定评估细胞活力,通过流式细胞术分析评估细胞凋亡。为了阐明基因相互作用,我们进行了 miRNA 表达的微阵列分析、双荧光素酶报告基因测定和 RNA 免疫沉淀。

结果

MSC 来源的外泌体表现出显著减轻 H9c2 细胞缺氧诱导的炎症和凋亡的能力。值得注意的是,这些外泌体显著上调了 H9c2 细胞内 miR-21-5p 的水平,而 miR-21-5p 功能的阻断减弱了它们的保护作用。通过计算分析,我们发现了 YAP1 的 3'UTR 中有一个 miR-21-5p 的结合位点,它直接抑制了 YAP1 的表达。重要的是,YAP1 的抑制有效恢复了缺失外泌体 miR-21-5p 的细胞中外泌体的保护作用。

结论

这项研究强调了 MSC 衍生的外泌体在保护心肌免受损伤中的关键作用,主要是通过介导 miR-21-5p 的转移,该 miR-21-5p 靶向 YAP1 信号通路。

临床试验编号

无。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c484/11465913/e07cde7c3fcb/12872_2024_4197_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c484/11465913/69ba12f770f4/12872_2024_4197_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c484/11465913/e2b3502abf5a/12872_2024_4197_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c484/11465913/7e2481e94c53/12872_2024_4197_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c484/11465913/edca7ec5802b/12872_2024_4197_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c484/11465913/a377fb0671a1/12872_2024_4197_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c484/11465913/35419eb81d27/12872_2024_4197_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c484/11465913/e07cde7c3fcb/12872_2024_4197_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c484/11465913/69ba12f770f4/12872_2024_4197_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c484/11465913/e2b3502abf5a/12872_2024_4197_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c484/11465913/7e2481e94c53/12872_2024_4197_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c484/11465913/edca7ec5802b/12872_2024_4197_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c484/11465913/a377fb0671a1/12872_2024_4197_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c484/11465913/35419eb81d27/12872_2024_4197_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c484/11465913/e07cde7c3fcb/12872_2024_4197_Fig7_HTML.jpg

相似文献

1
Mesenchymal stem cell-derived exosomal mir-21-5p inhibits YAP1 expression and improves outcomes in myocardial infarction.间充质干细胞衍生的外泌体 mir-21-5p 抑制 Yap1 表达并改善心肌梗死的预后。
BMC Cardiovasc Disord. 2024 Oct 10;24(1):547. doi: 10.1186/s12872-024-04197-z.
2
LncRNA KLF3-AS1 in human mesenchymal stem cell-derived exosomes ameliorates pyroptosis of cardiomyocytes and myocardial infarction through miR-138-5p/Sirt1 axis.长链非编码 RNA KLF3-AS1 可改善人骨髓间充质干细胞来源的细胞外囊泡介导的心肌细胞细胞焦亡及心肌梗死,其作用机制可能与 miR-138-5p/Sirt1 轴有关。
Stem Cell Res Ther. 2019 Dec 17;10(1):393. doi: 10.1186/s13287-019-1522-4.
3
Exosomal miR-25-3p from mesenchymal stem cells alleviates myocardial infarction by targeting pro-apoptotic proteins and EZH2.间充质干细胞来源的外泌体 miR-25-3p 通过靶向促凋亡蛋白和 EZH2 减轻心肌梗死。
Cell Death Dis. 2020 May 5;11(5):317. doi: 10.1038/s41419-020-2545-6.
4
MicroRNA-338 in MSCs-derived exosomes inhibits cardiomyocyte apoptosis in myocardial infarction.间充质干细胞来源的外泌体中的 microRNA-338 抑制心肌梗死后心肌细胞凋亡。
Eur Rev Med Pharmacol Sci. 2020 Oct;24(19):10107-10117. doi: 10.26355/eurrev_202010_23230.
5
Exosomes of bone-marrow stromal cells inhibit cardiomyocyte apoptosis under ischemic and hypoxic conditions via miR-486-5p targeting the PTEN/PI3K/AKT signaling pathway.骨髓基质细胞来源的外泌体通过 miR-486-5p 靶向 PTEN/PI3K/AKT 信号通路抑制缺血缺氧条件下的心肌细胞凋亡。
Thromb Res. 2019 May;177:23-32. doi: 10.1016/j.thromres.2019.02.002. Epub 2019 Feb 2.
6
Mesenchymal Stem Cell-Originated Exosomal Lnc A2M-AS1 Alleviates Hypoxia/Reperfusion-Induced Apoptosis and Oxidative Stress in Cardiomyocytes.间质干细胞源性外泌体 Lnc A2M-AS1 减轻心肌细胞缺氧/复氧诱导的细胞凋亡和氧化应激。
Cardiovasc Drugs Ther. 2023 Oct;37(5):891-904. doi: 10.1007/s10557-022-07339-7. Epub 2022 May 11.
7
Mesenchymal stem cell-derived exosomes ameliorate cardiomyocyte apoptosis in hypoxic conditions through microRNA144 by targeting the PTEN/AKT pathway.间充质干细胞衍生的外泌体通过 microRNA144 靶向 PTEN/AKT 通路减轻低氧条件下心肌细胞的凋亡。
Stem Cell Res Ther. 2020 Jan 23;11(1):36. doi: 10.1186/s13287-020-1563-8.
8
Exosomes from Hypoxic Pretreatment ADSCs Ameliorate Cardiac Damage Post-MI via Activated circ-Stt3b/miR-15a-5p/GPX4 Signaling and Decreased Ferroptosis.低氧预处理脂肪间充质干细胞来源的外泌体通过激活 circ-Stt3b/miR-15a-5p/GPX4 信号通路和减少铁死亡减轻心肌梗死后的心脏损伤。
Cardiovasc Toxicol. 2024 Nov;24(11):1215-1225. doi: 10.1007/s12012-024-09915-9. Epub 2024 Aug 27.
9
USP7, negatively regulated by miR-409-5p, aggravates hypoxia-induced cardiomyocyte injury.USP7 通过负调控 miR-409-5p 加重低氧诱导的心肌细胞损伤。
APMIS. 2021 Mar;129(3):152-162. doi: 10.1111/apm.13100. Epub 2020 Dec 12.
10
Mesenchymal stem cells-derived exosomes prevent sepsis-induced myocardial injury by a CircRTN4/miR-497-5p/MG53 pathway.间充质干细胞衍生的外泌体通过 CircRTN4/miR-497-5p/MG53 通路预防脓毒症诱导的心肌损伤。
Biochem Biophys Res Commun. 2022 Aug 27;618:133-140. doi: 10.1016/j.bbrc.2022.05.094. Epub 2022 Jun 3.

引用本文的文献

1
MSC-Derived Extracellular Vesicles: Roles and Molecular Mechanisms for Tissue Repair.间充质干细胞衍生的细胞外囊泡:组织修复中的作用和分子机制
Int J Nanomedicine. 2025 Jun 21;20:7953-7974. doi: 10.2147/IJN.S525394. eCollection 2025.
2
Exosomal non-coding RNAs: key regulators of inflammation-related cardiovascular disorders.外泌体非编码RNA:炎症相关心血管疾病的关键调节因子。
Eur J Med Res. 2025 May 19;30(1):395. doi: 10.1186/s40001-025-02649-6.
3
The effects of YAP/TAZ in cardiomyocytes: a scoping review.YAP/TAZ在心肌细胞中的作用:一项范围综述。

本文引用的文献

1
Exosomes as a Cell-free Therapy for Myocardial Injury Following Acute Myocardial Infarction or Ischemic Reperfusion.外泌体作为急性心肌梗死或缺血再灌注后心肌损伤的无细胞治疗方法。
Aging Dis. 2022 Dec 1;13(6):1770-1786. doi: 10.14336/AD.2022.0416.
2
Kidney tubular transcription co-activator, Yes-associated protein 1 (YAP), controls the expression of collecting duct aquaporins and water homeostasis.肾小管转录共激活因子Yes相关蛋白1(YAP)控制集合管水通道蛋白的表达和水平衡。
Kidney Int. 2023 Mar;103(3):501-513. doi: 10.1016/j.kint.2022.10.007. Epub 2022 Nov 1.
3
Exosomes Derived from Bone Marrow Mesenchymal Stem Cells Promote Angiogenesis in Ischemic Stroke Mice via Upregulation of MiR-21-5p.
Mol Biol Rep. 2025 Apr 15;52(1):392. doi: 10.1007/s11033-025-10492-5.
4
Stem-Cell Derived Exosomal microRNAs as Biomarkers and Therapeutics for Pediatric Cardiovascular Disease.干细胞衍生的外泌体微小RNA作为儿科心血管疾病的生物标志物和治疗方法
Curr Treat Options Cardiovasc Med. 2025;27(1):32. doi: 10.1007/s11936-025-01088-0. Epub 2025 Apr 9.
5
Mesenchymal stem cell-derived exosomes as a plausible immunomodulatory therapeutic tool for inflammatory diseases.间充质干细胞衍生的外泌体作为一种用于炎症性疾病的合理免疫调节治疗工具。
Front Cell Dev Biol. 2025 Mar 10;13:1563427. doi: 10.3389/fcell.2025.1563427. eCollection 2025.
6
Unpacking Exosomes: A Therapeutic Frontier for Cardiac Repair.解析外泌体:心脏修复的治疗前沿
Curr Cardiol Rep. 2025 Mar 20;27(1):73. doi: 10.1007/s11886-025-02225-8.
7
Protective activity of adipose-derived stem cell extracellular vesicles in ischemia and/or reperfusion.脂肪来源干细胞外泌体在缺血和/或再灌注中的保护作用。
World J Stem Cells. 2025 Jan 26;17(1):102280. doi: 10.4252/wjsc.v17.i1.102280.
骨髓间充质干细胞来源的外泌体通过上调 miR-21-5p 促进缺血性脑卒中小鼠的血管生成。
Biomolecules. 2022 Jun 24;12(7):883. doi: 10.3390/biom12070883.
4
Left ventricular remodelling post-myocardial infarction: pathophysiology, imaging, and novel therapies.心肌梗死后左心室重构:病理生理学、影像学及新疗法
Eur Heart J. 2022 Jul 14;43(27):2549-2561. doi: 10.1093/eurheartj/ehac223.
5
Critical role of PAFR/YAP1 positive feedback loop in cardiac fibrosis.PAFR/YAP1 正反馈环在心脏纤维化中的关键作用。
Acta Pharmacol Sin. 2022 Nov;43(11):2862-2872. doi: 10.1038/s41401-022-00903-9. Epub 2022 Apr 8.
6
Exosomes secreted by FNDC5-BMMSCs protect myocardial infarction by anti-inflammation and macrophage polarization via NF-κB signaling pathway and Nrf2/HO-1 axis.FNDC5-BMMSCs 分泌的外泌体通过 NF-κB 信号通路和 Nrf2/HO-1 轴发挥抗炎和巨噬细胞极化作用,从而保护心肌梗死。
Stem Cell Res Ther. 2021 Sep 28;12(1):519. doi: 10.1186/s13287-021-02591-4.
7
Loss of Yap/Taz in cardiac fibroblasts attenuates adverse remodelling and improves cardiac function.心脏成纤维细胞中 Yap/Taz 的缺失可减轻心脏重构并改善心功能。
Cardiovasc Res. 2022 Jun 22;118(7):1785-1804. doi: 10.1093/cvr/cvab205.
8
Macrophage migration inhibitory factor facilitates the therapeutic efficacy of mesenchymal stem cells derived exosomes in acute myocardial infarction through upregulating miR-133a-3p.巨噬细胞移动抑制因子通过上调 miR-133a-3p 促进间充质干细胞衍生的外泌体在急性心肌梗死中的治疗效果。
J Nanobiotechnology. 2021 Feb 27;19(1):61. doi: 10.1186/s12951-021-00808-5.
9
The Cell Type-Specific Functions of miR-21 in Cardiovascular Diseases.微小RNA-21在心血管疾病中的细胞类型特异性功能
Front Genet. 2020 Nov 20;11:563166. doi: 10.3389/fgene.2020.563166. eCollection 2020.
10
YAP/TAZ deficiency reprograms macrophage phenotype and improves infarct healing and cardiac function after myocardial infarction.YAP/TAZ 缺陷可重塑巨噬细胞表型,并改善心肌梗死后的梗死愈合及心脏功能。
PLoS Biol. 2020 Dec 2;18(12):e3000941. doi: 10.1371/journal.pbio.3000941. eCollection 2020 Dec.